Sep 17, 2025
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
Jun 19, 2025
111, Inc. Announces First Quarter 2025 Unaudited Financial Results
Mar 12, 2025
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
Feb 20, 2025
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
Feb 11, 2025
111, Inc. Regains Compliance with NASDAQ Requirement
Jan 08, 2025
111, Inc. Announces ADS Ratio Change
Nov 27, 2024
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Nov 21, 2024
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
Nov 04, 2024
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
Nov 04, 2024
111, Inc. Announces Change to Board of Directors
Oct 22, 2024
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
Oct 18, 2024
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow
Oct 10, 2024
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
Sep 27, 2024
111, Inc. Announces Receipt of Notification from Nasdaq
Aug 27, 2024
111, Inc. to Participate in Fireside Chat with Water Tower Research on September 5, 2024
Jul 29, 2024
111 to Announce Second Quarter 2024 Unaudited Financial Results on August 29, 2024 - Conference Call to Follow
Jun 11, 2024
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility
May 23, 2024
111, Inc. Announces First Quarter 2024 Unaudited Financial Results
Mar 01, 2024
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
Feb 27, 2024
111 Announces Receipt of Withdrawal of Going Private Proposal